Patents by Inventor Ernst Kuchler

Ernst Kuchler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dithiocarbamate antiviral agents and methods of using same
    Patent number: 7282599
    Abstract: The invention discloses a use of dithiocarbamate compounds having the structural formula R1R2NCS2H, in which R1 and R2, independently of each other, represent a straight or branched C1-C4 alkyl, or, with the nitrogen atom, form an aliphatic ring with 4 to 6 C atoms, in which R1, R2, or the aliphatic ring is optionally substituted with one or more substituents selected from OH, NO2, NH2, COOH, SH, F, Cl, Br, I, methyl or ethyl, and oxidized forms of these compounds, in particular dimers thereof, as well as pharmaceutically acceptable salts thereof, to prepare an agent for treating or preventing an infection by RNA viruses which attack the respiratory tract and cause disease there.
    Type: Grant
    Filed: July 15, 2002
    Date of Patent: October 16, 2007
    Assignee: Avir Green Hills Biotechnology Research Devlopment Trade AG
    Inventors: Elisabeth Gaudernak, Andreas Grassauer, Ernst Küchler, Thomas Muster, Joachim Seipelt
  • Use of a class of antiviral compounds for production of an agent for the treatment or prevention of a viral infection in the respiratory tract
    Publication number: 20060069153
    Abstract: The invention discloses a use of dithiocarbamate compounds having the structural formula R1R2NCS2H, in which R1 and R2, independently of each other, represent a straight or branched C1-C4 alkyl, or, with the nitrogen atom, form an aliphatic ring with 4 to 6 C atoms, in which R1, R2, or the aliphatic ring is optionally substituted with one or more substituents selected from OH, NO2, NH2, COOH, SH, F, Cl, Br, I, methyl or ethyl, and oxidized forms of these compounds, in particular dimers thereof, as well as pharmaceutically acceptable salts thereof, to prepare an agent for treating or preventing an infection by RNA viruses which attack the respiratory tract and cause disease there.
    Type: Application
    Filed: July 15, 2002
    Publication date: March 30, 2006
    Applicant: RATIER FIGEAC
    Inventors: Elisabeth Gaudernak, Andreas Grassauer, Ernst Kuchler, Thomas Muster, Joachim Seipelt
  • Expression of mature proteinase 2A, the partial purification thereof and preparation of substrates having an inhibitory effect
    Patent number: 5559025
    Abstract: The invention relates to the expression of mature HRV proteinase 2A, the partial purification thereof and the preparation of substrates having an inhibitory effect.
    Type: Grant
    Filed: October 11, 1994
    Date of Patent: September 24, 1996
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Horst Ahorn, Ingrid Maurer-Fogy, Wolfgang Sommergruber, Andreas Zophel, Dieter Blaas, Ernst Kuchler, Hans-Dieter Liebig, Timothy Skern